Research Study for People with Sinus Pressure or Pain - Clinical Trial

What is the Purpose of this Study?

If you choose to join this study you will:
-Be randomized (like the flip of a coin) to Group1 or Group 2
--Group 1 will get the study drug (Erenumab) once per month for 8 months
--Group 2 will get a placebo (harmess saltwater) once per month for 8 months
-Complete a pain diary daily
-Complete several questionnaires

What is the Condition Being Studied?

Facial Pain

Who Can Participate in the Study?

-Adults 18-65 years old
-Have a sinus infection and/or facial pain or pressure.

Age Group
Adults

What is Involved?

We are doing this study to test a drug, Erenumab, to see how well it works in lowering facial pain, pain medication use, and nose and sinus symptoms.

Study Details

Full Title
A Randomized, Double-Blinded, Single Site Study to Evaluate the Efficacy of Erenumab for Treatment of Idiosyncratic Facial Pain Mimicking Rhinosinusitis
Principal Investigator
Ear, Nose and Throat Doctor
Protocol Number
IRB: PRO00104284
NCT: NCT04249427
Phase
Phase IV
ClinicalTrials.gov
Enrollment Status
Open for Enrollment
Participate
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698